Innocoll: Innocoll Announces Successful Completion of Debt Refinancing
$125 million refinancing substantially improves Innocoll's liquidity, enabling further investment in pharmaceutical technology portfolio and growth plan ATHLONE, Ireland--(BUSINESS WIRE)-- ...
Read full article »
Innocoll is a New Jersey-based biotech pharmaceutical company that researches and develops collagen-infused medicinal products for postsurgical pain management.
Read more